R1 RCM (RCM) Prices 15M Share Secondary Offering at $22.50/Sh by Selling Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Pre-Open Stock Movers 05/26: (NBRV) (PIRS) (GME) Higher; (LRMR) (LOTZ) (TVTX) Lower (more...)
May 26, 2021 9:23 AM EDTPre-Open Stock Movers:
Nabriva Therapeutics (NASDAQ: NBRV) 49.3% HIGHER; Sinovant Sciences, a Chinese biopharmaceutical company dedicated to conducting innovative biomedical R&D in China, and Nabriva Therapeutics (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced positive topline results from Sinovants Phase 3 bridging study of lefamulin in Chinese adults with community acquired bacterial pneumonia (CABP).
R1 RCM (RCM) Announces Proposed 15M Share Secondary Offering by Selling Shareholders
May 26, 2021 6:11 AM EDTR1 RCM Inc. (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (TCP-ASC), a Delaware series limited liability limited partnership jointly owned by Ascension Health... More
